Research and Development

The Research and Development team at GV20 Therapeutics focuses on leveraging high-throughput functional genomics and AI technologies to identify and validate innovative cancer immunology drug targets. This multidisciplinary team collaborates to discover and advance novel antibody drugs, ensuring a robust pipeline of effective therapies for oncology applications. With expertise spanning bioinformatics, research, and scientific leadership, the team drives GV20's mission to revolutionize cancer treatment through cutting-edge drug discovery.